Inhibition of HDAC Activity by ITF2357 Ameliorates Joint Inflammation and Prevents Cartilage and Bone Destruction in Experimental Arthritis
Open Access
- 11 February 2011
- journal article
- Published by Springer Nature in Molecular Medicine
- Vol. 17 (5-6) , 391-396
Abstract
Inhibition of histone deacetylases (HDAC) has been shown to modulate gene expression and cytokine production after stimulation with several stimuli. In the present study, the antiinflammatory effect of a potent HDACi, ITF2357, was explored in different experimental models of arthritis. In addition, the bone protective effect of ITF2357 was investigated invitro. Treatment of acute arthritis (Streptococcus pyogenes cell wall (SCW) arthritis) with ITF2357 showed that joint swelling and cell influx into the joint cavity were reduced. Furthermore, the chondrocyte metabolic function was improved by treatment of ITF2357. The production of proinflammatory cytokines by synovial tissue was reduced after ITF2357 treatment. To examine the effect of HDAC inhibition on joint destruction, ITF2357 was applied to both rat adjuvant arthritis and mouse collagen type II arthritis. ITF2357 treatment both ameliorates the severity scores in arthritis models and prevents bone destruction. In an in vitro bone destruction assay, ITF2357 was highly effective at a dose of 100 nmol/L. In conclusion, inhibition of HDAC prevents joint inflammation and cartilage and bone destruction in experimental arthritis.Keywords
This publication has 42 references indexed in Scilit:
- Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritisArthritis Research & Therapy, 2010
- The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in VitroJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKLEuropean Journal of Pharmacology, 2009
- Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritisExperimental and Molecular Pathology, 2009
- Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritisModern Rheumatology, 2009
- Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injuryThe FASEB Journal, 2009
- Inhibition of histone deacetylases antagonized FGF2 and IL-1β effects on MMP expression in human articular chondrocytesGrowth Factors, 2009
- Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritisProceedings of the National Academy of Sciences, 2008
- TNF-induced structural joint damage is mediated by IL-1Proceedings of the National Academy of Sciences, 2007
- Anti‐rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen‐induced arthritis in rodentsBritish Journal of Pharmacology, 2007